Zobrazeno 1 - 10
of 68
pro vyhledávání: '"B. G. Durie"'
Autor:
D. Roodman, Brian B. G. Durie, Meletios A. Dimopoulos, Evangelos Terpos, Robert A. Kyle, Charalampia Kyriakou, Leonard Bastian, Noopur Raje, Ronald A. Alberico, Jeffrey A. Zonder, Sean Molloy, S. Vincent Rajkumar, Frank D. Vrionis, Sergio Giralt
Publikováno v:
Blood Cancer Journal, Vol 9, Iss 3, Pp 1-10 (2019)
Blood Cancer Journal
Blood Cancer Journal
Multiple myeloma (MM) represents approximately 15% of haematological malignancies and most of the patients present with bone involvement. Focal or diffuse spinal osteolysis may result in significant morbidity by causing painful progressive vertebral
Autor:
P, Sonneveld, B G, Durie, H M, Lokhorst, J P, Marie, G, Solbu, S, Suciu, R, Zittoun, B, Löwenberg, K, Nooter
Publikováno v:
Lancet (London, England). 340(8814)
Resistance to chemotherapy in refractory multiple myeloma is frequently associated with expression of multidrug resistance (MDR). In resistant cells, intracellular accumulation of doxorubicin and vincristine does not occur because the MDR-1 gene prod
Autor:
B G, Durie
Publikováno v:
Hematology/oncology clinics of North America. 6(2)
The last decade has seen major advances in the acquisition of knowledge concerning both the cellular and molecular genetics of multiple myeloma. Although discrete and specific changes associated with the plasma cell disorders have yet to be identifie
Autor:
B, Van Camp, B G, Durie, C, Spier, M, De Waele, I, Van Riet, E, Vela, Y, Frutiger, L, Richter, T M, Grogan
Publikováno v:
Blood. 76(2)
Bone marrow samples from 55 patients with multiple myeloma (MM) and 23 patients with monoclonal gammopathy of undertermined significance (MGUS) were evaluated with a broad panel of monoclonal antibodies. Plasma cells from 78% (43/55) of patients with
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 3(3)
We report the simultaneous expression of T-cell antigens on the myeloma cells from six patients with multiple myeloma (MM). These six patients come from a total population of 215 samples (115 direct samples, clinical incidence of 5.2%) of plasmacytic
Publikováno v:
Current topics in microbiology and immunology. 166
Autor:
B G, Durie, T M, Grogan
Publikováno v:
Blood. 66:229-232
Detailed immunotyping was carried out on 21 direct myeloma bone marrow aspirates and eight human myeloma cell lines. Four previously untreated common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma patients were identified and six of ei
Publikováno v:
Blood. 73:763-769
In a four year span, between 1983 and 1987, 215 bone marrow and cell culture samples from 125 myeloma patients were immunotyped and coexpression of myelomonocytic and plasma cell antigens occurred in 16 (13%). We employed both immunohistochemical and
Autor:
B G, Durie, E, Vela, V, Baum, A, Leibovitz, C M, Payne, L C, Richter, T M, Grogan, J M, Trent
Publikováno v:
Blood. 66:548-555
Two new human myeloma cell lines have been established from a 36-year- old woman with refractory IgG kappa multiple myeloma in whom bilateral malignant pleural effusions developed. The malignant plasma cells from each effusion were set up in a liquid
Autor:
A C Buzaid, B G Durie
Publikováno v:
Journal of Clinical Oncology. 6:889-905
Management of refractory myeloma represents a common and challenging clinical problem. Approximately 30% to 50% of patients with multiple myeloma do not respond to first-line therapy, and those who initially achieve a remission will eventually relaps